//
D. Hart
R. Sidonio
S. Ahuja
M. Carcao
Y. Dargaud
M. Escobar
C. Kessler
O. Khan
C. Leissinger
P. Maes
M. Mancuso
W. Miesbach
M. Simpson
M. Wang
H. Wang
A. Srivastava
Royal London Haemophilia Centre, Barts and the London School of Medicine and Dentistry, London, United Kingdom
Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, United States
UNC Hemophilia and Thrombosis Center; University of NC at Chapel Hill, Chapel Hill, North Carolina, United States
Rainbow Babies and Children's Hospital, Cleveland, OH, USA, Cleveland, Ohio, United States
Hospital Universitario La Paz, Madrid, Spain
Division of Haematology/Oncology, Department of Paediatrics and Research Institute, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada
GEMMAT, Groupe d'Etude Multidisciplinaire en Maladies Thrombotiques, Lyon, France4 Service de Médecine Intensive Réanimation, Hôpital Edouard Herriot, Lyon, France ; Unité d'Hémostase Clinique Hôpital Cardiologique Louis Pradel, Lyon, France ; UR4609 Hémostase & Thrombose, Université Claude Bernard Lyon 1, Lyon, LYON, Rhone-Alpes, France
University of Texas Health Science Center at Houston - Medical School, Houston, Texas, United States
Georgetown University School of Medicine, Washington, Dist. of Columbia, United States
University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, United States
Tulane University, New Orleans, LA, United States
Antwerp University Hospital, Edegem, Belgium
IRCCS Humanitas Research Hospital, Milan, Lombardia, Italy
Unidad de Investigación Medica de Trombosis, Hemostasia y Aterogénesis. Instituto Mexicano del Seguro Social, Ciudad de Mexico, Distrito Federal, Mexico
Rush University Medical Center, Chicago, Illinois, United States
University of Colorado Hemophilia & Thrombosis Center, Aurora, United States
HEMA Biologics, Louisville, Kentucky, United States
NHLBI, Framingham, Massachusetts, United States
Christian Medical College, Vellore, India, Vellore, Tamil Nadu, India
United Kingdom
United States
Spain
Canada
France
Belgium
Italy
Mexico
Germany
India
N/A
Blood/haematological Diseases
Hemophilia
Cancer antigen 15-3
N/A
N/A
N/A
III
NCT02020369
N/A
N/A